| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 229.29B | 245.55B | 254.40B | 246.72B | 204.61B |
| Gross Profit | 42.30B | 37.19B | 30.78B | 7.50B | 41.77B |
| EBITDA | 58.21B | 51.71B | 47.04B | 24.13B | 16.44B |
| Net Income | 14.41B | 10.14B | 8.45B | -10.08B | -13.19B |
Balance Sheet | |||||
| Total Assets | 611.79B | 586.84B | 541.16B | 502.61B | 500.77B |
| Cash, Cash Equivalents and Short-Term Investments | 19.46B | 19.93B | 16.85B | 17.18B | 16.35B |
| Total Debt | 276.91B | 256.93B | 253.78B | 300.51B | 297.70B |
| Total Liabilities | 399.27B | 383.79B | 369.80B | 376.06B | 367.21B |
| Stockholders Equity | 142.47B | 137.41B | 52.51B | 108.54B | 113.05B |
Cash Flow | |||||
| Free Cash Flow | 8.89B | -13.12B | -13.88B | -8.21B | -37.45B |
| Operating Cash Flow | 67.21B | 50.53B | 45.50B | 32.52B | 6.03B |
| Investing Cash Flow | -57.29B | -63.60B | -55.23B | -39.97B | -42.66B |
| Financing Cash Flow | -10.50B | 15.48B | 9.42B | 7.97B | 39.77B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | HK$96.86B | 6.06 | 12.76% | 5.89% | 1.42% | -10.32% | |
66 Neutral | $17.65B | 18.10 | 5.60% | 3.62% | 6.62% | 11.55% | |
62 Neutral | HK$241.44B | 13.97 | 7.98% | 3.50% | -1.16% | -14.97% | |
61 Neutral | HK$67.69B | 5.00 | 9.77% | 5.62% | -0.44% | 333.39% | |
61 Neutral | HK$58.12B | 7.66 | 9.76% | 5.73% | 8.09% | 24.77% | |
56 Neutral | HK$114.16B | 6.58 | 11.62% | 4.74% | -3.78% | 34.93% | |
56 Neutral | HK$39.21B | 10.82 | 5.96% | 6.83% | 4.20% | -5.31% |